Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest ExpensesInterest Income - NetInterest Income - TotalNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Serina Therapeutics (SER) Shares Outstanding (2017 - 2025)

Serina Therapeutics (SER) has disclosed Shares Outstanding for 9 consecutive years, with $10.8 million as the latest value for Q4 2025.

  • Quarterly Shares Outstanding rose 14.28% to $10.8 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $10.8 million through Dec 2025, up 14.28% year-over-year, with the annual reading at $10.8 million for FY2025, 14.28% up from the prior year.
  • Shares Outstanding hit $10.8 million in Q4 2025 for Serina Therapeutics, up from $10.5 million in the prior quarter.
  • In the past five years, Shares Outstanding ranged from a high of $37.9 million in Q3 2022 to a low of $1079.0 in Q4 2021.
  • Historically, Shares Outstanding has averaged $13.4 million across 5 years, with a median of $8.8 million in 2024.
  • Biggest YoY gain for Shares Outstanding was 200734.11% in 2022; the steepest drop was 99.9% in 2022.
  • Year by year, Shares Outstanding stood at $1079.0 in 2021, then skyrocketed by 200734.11% to $2.2 million in 2022, then grew by 11.21% to $2.4 million in 2023, then surged by 290.95% to $9.4 million in 2024, then rose by 14.28% to $10.8 million in 2025.
  • Business Quant data shows Shares Outstanding for SER at $10.8 million in Q4 2025, $965000.0 in Q3 2025, and $10.1 million in Q2 2025.